ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,569.90
0.00%
S&P ASX All Technology
2,968.80
0.00%
Brent Oil
83.615
0.09%
US Dollar vs AUD
1.53131
-0.83%
Bitcoin
58,284.91
0.08%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Taro Pharmaceutical Industries Ltd (TARO)

  7. Taro Pharmaceutical Industries Ltd (TARO) News

TARO Taro Pharmaceutical Industries Ltd

42.39
-0.09 (-0.21%)
After Hours
Last Updated: 06:32:30
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Taro Pharmaceutical Industries Ltd TARO NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.09 -0.21% 42.39 06:32:30
Open Price Low Price High Price Close Price Previous Close
42.60 42.24 42.67 42.39 42.48
more quote information »

Recent News

Date Time Source Heading
15/4/202422:00BWTaro Announces Extraordinary General Meeting and Ordinary..
11/3/202421:19EDGAR2Form SC 13E3/A - Going private transaction by certain..
16/2/202400:36EDGAR2Form SC 13E3 - Going private transaction by certain issuers
31/1/202405:18PRNUSKuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to..
30/1/202423:00PRNUSKrensavage Asset Management Remains Opposed to Sun's..
27/1/202401:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/1/202409:06BWTaro Provides Results for December 31, 2023
20/1/202408:15BWTaro to Release Third Quarter Results on January 25, 2024
18/1/202408:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/1/202408:35EDGAR2Form SC 13D/A - General statement of acquisition of..
18/1/202408:30PRNCATaro Announces Merger Agreement with Sun Pharma
05/1/202408:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202308:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202308:30EDGAR2Form SC 13D/A - General statement of acquisition of..
18/11/202308:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/10/202300:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/10/202308:00BWTaro Provides Results for September 30, 2023
20/10/202307:30BWTaro to Release Second Quarter Results on October 26, 2023
28/7/202300:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/7/202310:36BWTaro Provides Results for the Quarter Ended June 30, 2023
20/7/202306:00BWTaro to Release First Quarter Results on July 26, 2023
19/7/202321:00PRNUSKrensavage Asset Management Opposes Sun's Lowball Bid for..
30/6/202323:00BWTaro Annual Report on Form 20-F Available For Fiscal Year..
30/6/202306:32EDGAR2Form 20-F - Annual and transition report of foreign private..
29/6/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/5/202309:00BWTaro Provides Results for Year Ended March 31, 2023
19/5/202306:46BWTaro to Release Full Year Results on May 23, 2023

Your Recent History

NYSE
TARO
Taro Pharmaceutical Indu...
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved